Unveiling Non-Internalizing ADC: Linker-Payload Technologies & Clinical Products

6:15 pm - Tuesday 9th March 2027

  • Highlighting current non-internalizing ADC linker-payload technologies and its challenges
  • Demonstrating in vitro and in vivo mechanistic studies with TMALIN ADC technology
  • Sharing clinical product examples from TMALIN linker-payload technology to achieve better efficacy, low toxicity and a bigger ADC target space

Speakers:

Co-founder ,Chief Scientific Officer & Co-Chief Executive Officer
Medilink Therapeutics